NEDNA

Welcome to the Brand page for “NEDNA”, which is offered here for Vaccines; dna based vaccines; dna extracts, nucleic acid sequences and chemical reagents for medical use; therapeutic dna, nucleic acid sequences and chemical reagents for medical and veterinary purposes; biotechnological product, viral dna vector, for delivery of genes and other materials, rna and transcriptional targeting promoters, to a biological cell for medical purposes; dna for production of viral vectors;chemical preparations, enzymes and dna for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of dna extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of dna extracts and cassettes for scientific and industrial purposes; dna extracts and cassettes for scientific and research use; dna extracts for use in agri-biotechnology and nanotechnology; biological and biochemical reagents forming a gene analysis system-, rna polymerase, dna plasmid vectors and rna markers; diagnostic reagents for scientific or research purposes, a kit including a dna plasmid vectors;scientific and technological services, research and design in the field of dna research and development; chemical and biological analysis and research services; scientific research in the field of dna; scientific research and development in the field of creation of dna extracts; scientific research, analysis, design and development relating to dna based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; consultancy in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology and dna analysis;.

Its status is currently believed to be active. Its class is unavailable. “NEDNA” is believed to be currently owned by “Asklepios BioPharmaceutical, Inc.”